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study. Inhibition of basal autophagy was achieved using CQ, HCQ and
Baﬁlomycin A1 (Baf A1) in multiple human bladder cancer cell lines. Cell
viability was assessed byWST-1 assay.Western blot detection of LC3-II was
performed to monitor autophagy, while detection of caspase 3/7 activities
and DNA fragmentationwere conducted to investigate apoptotic induction
in treated cells. The disruption of mitochondria membrane potential
(MMP), the generation of reactive oxygen species (ROS) and lysosome
permeability were accessed by JC-1, H2DCFDA staining and IF detection of
cathepsin D and E, respectively, in CQ- and HCQ-treated cells.
Results: Changes in LC3 ﬂux, monitored by Western blot and IF, indicated
inhibition of autophagy at the level of the autophagosome by CQ and HCQ.
Both two autophagy inhibitors induced cytotoxicity in multiple human
bladder cell lines in time- and dose-dependent manner especially in
advanced cancer cell lines. CQ and HCQ also signiﬁcantly impacted the
clonogenic formation of bladder cancer cells. However, the inhibition of
cell viability was only observed in bladder cancer cell lines but not in SV-
Huc-1, PC3 and MCF-7 cells that reported to be with low basal autophagy
activity. Induction of apoptosis was found in cells treated with CQ and
HCQ. We cannot detected the disruption of mitochondria membrane po-
tential nor the generation of reactive oxygen species in CQ- or HCQ-treated
cells. Translocation of cathepsin B in CQ-treated cells suggesting the
change of lysosome permeability that leads to the blockage of autophagy
and increasing apoptotic cell death by these agents.
Conclusion: Targeting autophagy with CQ or HCQ may be an effective
cancer therapy in human bladder cancer.
PD7-5:
INHIBITION OF AUTOPHAGY POTENTIATES APOPTOSIS IN BITC-
TREATED HUMAN BLADDER CANCER CELLS
Te-Fu Tsai 1,4,a, Ji-Fan Lin 2,a, Shan-Che Yang 2, Hung-En Chen 1, Yi-Chia
Lin 1,4, Kuang-Yu Chou 1,4, Thomas I-Sheng Hwang 1,3,4. 1Division of
Urology, Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital,
Taiwan; 2Central Laboratory, Shin Kong Wu Ho-Su Memorial Hospital,
Taiwan; 3 School of Medicine, Taipei Medical University, Taiwan; 4 School of
Medicine, Fu-Jen Catholic University, Taipei, Taiwan
Purpose: Benzyl isothiocyanate (BITC) is contained in cruciferous plants
which are part of the human diet, and has been shown to induce apoptosis
in varies cancer cell lines including human bladder cancer cells. In our
previous work, we showed that BITC induces protective autophagy via
inhibition of mTOR signaling pathway in prostate cancer cells. And the
induced apoptosis and autophagy in human prostate cancer cells were
mediated by BITC-induced ROS generation. Here we investigated weather
inhibition of autophagy enhances apoptosis in human bladder cancer cells
as a novel therapeutic strategy.
Materials and Methods: Human bladder cancer cell lines including
grade II, 5637, and grad III, T24, were used in this study. We also included
mouse bladder cancer cell line, MBT2, for the development of orthotopic
mice bladder cancer model for further study. Baﬁlomycin A1 (Baf A1) and
chloroquine (CQ) were used as autophagy inhibitors. Cell viability in
BITC-treated cells with or without the pretreatment of autophagy in-
hibitors were measured by WST-1 reagent. Detection of autophagy was
conducted by measuring the LC3-II processing and the accumulation of
p62 by Western blotting and immunoﬂuorescent staining of these
marker protein. Detection of apoptosis was performed by the monitored
the caspase 3/7 activity, Western blot of cleavage caspase3 and cell
ﬂowcytometry of DNA fragmentation in treated cells. Detection of
autophagy was conducted by measuring the LC3-II processing and the
accumulation of p62.
Results: Exposure of 5637, T24 and MBT2 cells to pharmacologic concen-
trations of BITC resulted in the decrease of cell viability and autophagy
induction. Although inhibition of basal autophagy by Baf A1 or CQ alone
caused cell viability loss in these bladder cancer cell lines, pre-treatment of
Baf A1 or CQ to inhibit BITC-induced autophagy further enhanced the in-
hibition of cell growth. Enhanced apoptosis judged by the increased cas-
pase 3/7 activity, increased amount of cleaved caspase 3 and elevated level
of DNA fragmentation in BITC-treated cell with Baf A1 or CQ pretreatment
suggesting inhibition of autophagy signiﬁcantly potentiates the anti-can-
cer effect of BITC in human bladder cancer cells.Conclusion: This is the ﬁrst study showed that inhibition of autophagy
induced by BITC markedly enhance apoptosis in human and mouse
bladder cancer cells. We are currently using orthotopic mice bladder
cancer model to translate our results from in vitro to in vivo studies. Our
data may be beneﬁcial for further development of novel therapeutic
strategies against bladder cancer.
PD7-6:
THROMBOMODULIN EXPRESSION REGULATES TUMORIGENESIS IN
BLADDER CANCER
Chun-Te Wu1,4, Ying-Hsu Chang 2,4, Wen-Cheng Chen 3,4, Miao-Fen
Chen 3,4. 1Division of Urology, Chang Gung Memorial Hospital, Keelung,
Chiayi, Taiwan; 2 Linko, Chiayi, Taiwan; 3 Taiwan Division of Radiation
Oncology, Chiayi, Taiwan; 4 School of Medicine, Chang Gung University,
Taoyuan, Taiwan
Purpose: The identiﬁcation of potential tumor markers will help improve
therapeutic planning and patient management. Thrombomodulin (TM) is a
sensitive urothelial marker. TM was reported to be one of the endogenous
anti-metastatic factors and has diagnostic and prognostic values for the
progression of carcinoma. In the present study, we examine the role of TM
in bladder cancer.
Materials and Methods:We studied the role of TM in tumor behavior and
related signaling pathways in vitro using the human bladder cancer cell
lines HT1376, HT1197, J82 and T24, and in vivo using animal models. We
also selected clinical specimens from 100 patients with bladder cancer for
immunohistochemical staining to evaluate the predictive capacity of TM in
tumor invasiveness.
Results: The data revealed that positive immunoreactivity for TM was
inversely correlated with clinical stage and DNA methyltransferase 1
immunoreactivity. Decreased TM expression could predict the aggressive
tumor growth and advanced clinical stage in bladder cancer.When TMwas
inhibited, tumor growth rate and invasion ability were augmented in vitro
and in vivo. The underlying changes included increased cell proliferation,
enhanced epithelial-mesenchymal transition (EMT) and angiogenesis.
Moreover, inhibition of NF-kB activation signiﬁcantly increased TM
expression and attenuated tumor aggressiveness in bladder cancer.
Conclusion: TM plays an important role in bladder cancer tumor aggres-
siveness in vitro and in vivo and is a clinically signiﬁcant predictor that
may represent a suitable therapeutic target for bladder cancer.Podium-8
Oncology
PD8-1:
URETERAL INVOLVEMENT AND DIABETES INCREASE THE RISK OF
SUBSEQUENT BLADDER RECURRENCE AFTER NEPHROURETERECTOMY
FOR UPPER URINARY TRACT UROTHELIAL CARCINOMA
Che-Yuan Hu 1, Yu-Chieh Tsai 2, Shuo-Meng Wang 1, Chao-Yaun
Huang 1, Huai-Ching Tai 1, Chung-Hsin Chen 1, Yeong-Shiau Pu 1, Wei-
Chou Lin 3, Kuo-How Huang 1. 1Department of Urology, National Taiwan
University Hospital, Taipei, Taiwan; 2Department of Oncology, National
Taiwan University Hospital, Taipei, Taiwan; 3Department of Pathology,
National Taiwan University Hospital, Taipei, Taiwan
Purpose: To investigate the prognostic factors for bladder recurrence after
radical nephroureterectomy (RNU) in patients with upper urinary tract
urothelial carcinoma (UUT-UC)
Materials and Methods: From 1994 to 2012, 695 patients with UUT-UC
treated with RNU were enrolled in National Taiwan University Medical
Center. Among them, 532 patients with no prior bladder UC histories were
recruited for analysis. We assessed the impact of potentially prognostic
factors on bladder recurrence after RNU.
Results: The median follow-up period was 47.8 months. In the Cox model,
ureteral involvement and diabetes mellitus (DM) were signiﬁcantly asso-
ciated with a higher bladder recurrence rate in the multivariate analysis
(hazard ratio [HR]: 1.838; p¼ 0.003 and HR: 1.821; p¼ 0.010, respectively).
In the Kaplan-Meier analysis, DM patients with concomitant ureteral UC
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compared to those without both factors (HR: 3.222; p< 0.001). Patients
with either one of the two risk factors experienced about a two-fold
increased risk as compared to those without both factors (with DM, HR:
2.184, p ¼ 0.024; with ureteral involvement, HR: 2.006, p ¼ 0.003).
Conclusion: Ureteral involvement and DM are signiﬁcantly related to
bladder recurrence after RNU in patients with UUT-UC.
PD8-2:
HYDRONEPHROSIS INDEPENDENTLY PREDICTS WORSE OUTCOME OF
UPPER TRACT UROTHELIAL CARCINOMA IN PATIENTS PRESENTING
WITH SIMULTANEOUS FLANK PAIN
Hsin-Chih Yeh 1,2, Ching-Chia Li 1,2, Chun-Nung Huang 2, Hung-Lung
Ke 2, Wei-Ming Li 2, Wen-Jeng Wu 2. 1Department of Urology, Kaohsiung
Municipal Ta-Tung Hospital, Kaohsiung, Taiwan; 2Department of Urology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
Purpose: We aimed to investigate the impact of preoperative hydro-
nephrosis (HN) and ﬂank pain on prognosis of patients with upper tract
urothelial carcinoma (UTUC).
Materials and Methods: In total, 472 patients with UTUC managed by
radical nephroureterectomy were included from Kaohsiung Medical Uni-
versity Hospital Healthcare System. Clinicopathological data were
collected retrospectively for analysis. The signiﬁcance of HN, especially
when combined with ﬂank pain, and other relevant factors on cancer-
speciﬁc survival (CSS) and overall survival (OS) were evaluated.
Results: Of the 472 patients, 292 (62%) had preoperative HN and 121
(26%) presented with ﬂank pain. Preoperative HN was signiﬁcantly
associated with age, ﬂank pain, tumor location, and pathological tumor
stage. Preoperative HN and ﬂank pain were signiﬁcant predictors of
non-organ-conﬁned (NOC) UTUC (p ¼ 0.020 and 0.013, respectively).
Kaplan-Meier analysis showed signiﬁcantly poorer OS and CSS in pa-
tients with preoperative HN (p ¼ 0.005 and p ¼ 0.026, respectively) and
in patients with ﬂank pain (p < 0.001 and p ¼ 0.001, respectively) than
those without. However, only simultaneous HN and ﬂank pain inde-
pendently predicted adverse outcome (HR ¼ 2.47, p < 0.001 for OS and
HR ¼ 2.28, p ¼ 0.002 for CSS, respectively) in multivariate Cox pro-
portional hazards models. Notably, there was no difference in survival
between patients with HN but devoid of ﬂank pain and those without
HN.
Conclusion: Both preoperative HN and ﬂank pain predicted NOC UTUC.
When accompanied with ﬂank pain, HN represented an independent
predictor for worse outcome in patients with UTUC.
PD8-3:
INFERIOR SURVIVAL, HIGHER TUMOR RECURRENCE AND PROGRESSION
RATES IN PRIMARY NON-MUSCLE-INVASIVE BLADDERCANCER WITH
IMPAIRED EGFR
Chia-En Li 2, Hui-Ying Liu 1, Chih-Hsiung Kang 1, Ye-In Chang 2, Hsiu-Pei
Tang 2. 1Department of Urology, Chang Kung Memorial Hospital,
Kaohsiung, Taiwan; 2Department of Computer Science and Engineering,
National Sun Yat-sen University, Kaohsiung, Taiwan
Purpose: To evaluate the inﬂuence of preoperative patient-associated
parameters and comorbidities, with special focus on preoperative renal
function on non-muscle-invasive bladder cancer (NMIBC) recurrence,
progression, upper urinary tract (UUT) recurrence, cancer speciﬁc survival
and overall survival.
Materials and Methods: Medical records of 158 patients with ﬁrst diag-
nosis of NMIBC from 2008 to 2010 treated at our department were
reviewed for tumor stage and grade, comorbidities, and putative risk
factors including squamous differentiation, tumor size and count, white
blood cell (WBC), neutrophil to lymphocyte ratio (NL ratio), estimated
glomerular ﬁltration rate (eGFR) by chronic kidney disease-epidemiology
collaboration formula, patient age and gender.
Results: Tumor recurrence was observed in 51 patients (32%) and UUT
recurrence was 5 patients (3%); progression to higher pT was found in 9
patients (6%). Univariate analysis revealed count, grade, size, stage, eGFR
and squamous differentiation as signiﬁcation prediction determinantsfor bladder recurrence. Count, grade, stage, eGFR were signiﬁcation
prediction determinants for progression. Age, grade, stage and eGFR
were signiﬁcation prediction determinants for overall survival. Based on
the results of multivariate analysis, a risk factor model was created to
classify patients with high and low risk of recurrence, progression and
survival.
Conclusion: eGFR, grade and stage are signiﬁcant predictive variables of
NMIBC recurrence, progression and survival. Integrating eGFR into NMIBC
risk calculation helped to discriminate individuals with high and low risk
of cancer recurrence, progression and survival. Conﬁrmatory studies and
external validation are needed to corroborate these ﬁndings.
PD8-4:
THE PREDICTIVE FACTORS FOR CONCURRENT RENAL PELVIS TUMOR OF
PATIENTS WITH URETER CARCINOMA: KAOHSIUNG CHANG GUNG
MEMORIAL HOSPITAL EXPERIENCE
Cheng-Jen Yu, Po-Hui Chiang, Hao-Lun Luo. Department of Urology,
Kaohsiung Chang Gung Memorial Hospital and Chang Gung University
College of Medicine, Kaohsiung, Taiwan
Purpose: The incidence of upper tract urothelial carcinoma (UTUC) and
chronic kidney disease (CKD) are high in southern Taiwan. The renal
sparing surgery (RSS) is an optional choice of treatment of UTUC. This
study was designed to assess the predictive factors on multifocal UTUC.
Materials and Methods: This study was retrospectively designed to
determine the predictive factors on concurrent renal pelvis urothelial
carcinoma (RPUC). From 2004 to 2012, 263 patients with preoperative
solitary ureter tumor underwent radical nephroureterectomy (RNU) at our
tertiary medical center. Perioperative data were recorded by chart review.
Multivariate binary logistic regression was used to analyze the impact of
risk factors for concurrent RPUC by SPSS ver. 17.
Results: There are thirty-eight patients (14%) had postoperative ﬁnding of
concurrent RPUC. There is no signiﬁcant difference of grade of preopera-
tive hydronephrosis between both groups (p ¼ 0.533), and there are sig-
niﬁcant difference of proportion of preoperative CKD stage (p¼ 0.005) and
past history of bladder cancer (p ¼ 0.003) between both groups. Multi-
variate analysis disclosed both bladder cancer history (odds ratio: 2.948;
p ¼ 0.005) and preoperative CKD stage >3 (odds ratio: 2.207; p ¼ 0.033)
are independent risk factors for multifocal UTUC.
Conclusion: In addition to the EAU guideline of conservative treatment for
UTUC, we supposed that past history of bladder cancer and preoperative
CKD stage greater than stage 3 are both important and independent risk
factors to synchronously multifocal UTUC. More consequent studies about
the oncologic outcome of RSS are necessary.
PD8-5:
IS THE CALCIFIED LESION OF BLADDER WALL AFTER INTRAVESICAL
MITOMYCIN-C THERAPY FOR SUPERFICIAL BLADDER CANCER SHOULD
BE RESECTED?
Jing-Dung Shen 1,2, Jane-Dar Lee 1, Tai-Lung Cha 2, Guang-Haun Sun 2, Dah-
Shyong Yu 2, Sun-Yran Chang 2, En Meng 2. 1Divisions of Urology,
Department of Surgery, Taichung Armed Forces General Hospital, Taichung,
Taiwan; 2Division of Urology, Departments of Surgery, Tri-Service General
Hospital, National Defense Medical Center, Taipei, Taiwan
Purpose: Intravesical therapy with Mitomycin-C and Bacillus Calmette-
Guerin is a standard treatment for superﬁcial bladder cancer. Owing to the
worldwide shortage of Bacillus Calmette-Guerin, the use of Mitomycin-C
for intravesical therapy is increasing. Sometimes, calciﬁed lesion of bladder
wall at previous resection site were found during scheduled cystoscopy.
Are these lesions should be resected?
Materials and Methods: We retrospectively included 43 non-muscle
invasive bladder cancer patients who were treated with transurethral
resection of bladder tumor followed by adjuvant intravesical mitomycin C
intravesical therapy between 2011 and 2014 at Tri-service General Hos-
pital. These patients were classiﬁed into calciﬁcation and non-calciﬁcation
groups. This study analyzes the characteristic of these two groups in order
to ﬁnd the predictive factor of bladder wall calciﬁcation and the meaning
of bladder wall calciﬁcation in clinical practice.
